NPI: 1427024819 · WASHINGTON, DC 20018 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 44,257 | $637K |
| 2019 | 37,940 | $490K |
| 2020 | 29,454 | $517K |
| 2021 | 28,625 | $409K |
| 2022 | 30,288 | $525K |
| 2023 | 14,737 | $478K |
| 2024 | 5,564 | $450K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 62,922 | 4,715 | $3.03M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 47,530 | 2,951 | $365K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,138 | 468 | $51K |
| J1756 | Injection, iron sucrose, 1 mg | 12,406 | 2,968 | $42K |
| J1270 | Injection, doxercalciferol, 1 mcg | 35,123 | 2,975 | $10K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 2,314 | 661 | $6K |
| J1644 | Injection, heparin sodium, per 1000 units | 533 | 74 | $637.98 |
| 90674 | 106 | 101 | $582.99 | |
| 83970 | 3,147 | 2,361 | $545.08 | |
| 0012A | 18 | 18 | $423.90 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,874 | 1,539 | $349.51 |
| 0064A | 19 | 19 | $280.26 | |
| 0124A | 43 | 17 | $201.12 | |
| 0011A | 22 | 22 | $152.46 | |
| 82728 | 2,115 | 1,676 | $98.01 | |
| G0008 | Administration of influenza virus vaccine | 139 | 110 | $97.00 |
| 83550 | 2,055 | 1,662 | $62.09 | |
| 82108 | 553 | 512 | $51.65 | |
| 83540 | 2,170 | 1,726 | $48.32 | |
| 85041 | 3,471 | 2,574 | $46.65 | |
| 85048 | 3,372 | 2,537 | $38.45 | |
| 82607 | 266 | 234 | $24.01 | |
| 82746 | 304 | 269 | $23.41 | |
| A4657 | Syringe, with or without needle, each | 8,200 | 3,454 | $14.15 |
| 87340 | 25 | 23 | $0.00 |